Zobrazeno 1 - 10
of 29
pro vyhledávání: '"N. Tomaszewski"'
Autor:
Archana Thakur, Johnson Ung, Elyse N. Tomaszewski, Amy Schienschang, Timothy M. LaBrie, Dana L. Schalk, Lawrence G. Lum
Publikováno v:
OncoImmunology, Vol 10, Iss 1 (2021)
In this study, we investigated the ability of bispecific antibody armed activated T cells to target drug resistant pancreatic cancer cells and whether or not “priming” these resistant cancer cells with bispecific antibody armed activated T cells
Externí odkaz:
https://doaj.org/article/3062abc026db4ed09e0ef23859a8ffd7
Publikováno v:
Journal of Investigative Dermatology. 142:S35
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::34b55153b84851bb15854de099bbdd31
https://doi.org/10.1016/j.jid.2022.05.214
https://doi.org/10.1016/j.jid.2022.05.214
Autor:
Dana L Schalk, Archana Thakur, Timothy M LaBrie, Johnson Ung, Lawrence G. Lum, Amy Schienschang, Elyse N. Tomaszewski
Publikováno v:
Oncoimmunology
article-version (VoR) Version of Record
OncoImmunology, Vol 10, Iss 1 (2021)
article-version (VoR) Version of Record
OncoImmunology, Vol 10, Iss 1 (2021)
In this study, we investigated the ability of bispecific antibody armed activated T cells to target drug resistant pancreatic cancer cells and whether or not “priming” these resistant cancer cells with bispecific antibody armed activated T cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5646cd1cc8ada9052fd6bcc7dcfc851
http://europepmc.org/articles/PMC8172155
http://europepmc.org/articles/PMC8172155
Autor:
K. Capozza, N. Tomaszewski, S. Eftekhari, K. Batra, Katrina Abuabara, K.Z. Tullos, W. Smith Begolka
Publikováno v:
Journal of Investigative Dermatology. 141:S63
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c13f82f6c5816f3914bc0f86d5605de7
https://doi.org/10.1016/j.jid.2021.02.385
https://doi.org/10.1016/j.jid.2021.02.385
Publikováno v:
Journal of Investigative Dermatology. 140:S62
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b41a3dd2c3487bbe76caf4119c768ca5
https://doi.org/10.1016/j.jid.2020.03.474
https://doi.org/10.1016/j.jid.2020.03.474
Autor:
Zaid Al-Kadhimi, Hiroshi Yano, Muneer H. Abidi, Dana Schalk, Lois Ayash, Melissa Dufresne, Archana Thakur, Abhinav Deol, Patricia A. Steele, Qin Liu, Lawrence G. Lum, Joseph P. Uberti, Voravit Ratanatharathorn, Elyse N. Tomaszewski, Alice Mitchell, Cassara Pray
Publikováno v:
Biology of Blood and Marrow Transplantation. 19(6):925-933
A phase I trial of infusing anti-CD3 × anti-CD20 bispecific antibody (CD20Bi) armed activated T cells (aATC) was conducted in high-risk/refractory non-Hodgkin's lymphoma patients to determine whether aATC infusions are safe, affect immune recovery,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93a88c9b55ebb35358f2bfd78712e1a2
Autor:
Elyse N. Tomaszewski, Lawrence G. Lum, Lois Ayash, Hiroshi Yano, Muneer H. Abidi, Sri Vidya Kondadasula, Dana Schalk, Voravit Ratanatharathorn, Archana Thakur, Joseph P. Uberti, Abhinav Deol, Zaid Al-Kadhimi, Jeffrey A. Zonder
Publikováno v:
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 22(5)
This phase Ib clinical trial evaluated whether pretargeting of CD20+ clonogenic myeloma precursor cells (CMPCs) with anti-CD3 × anti-CD20 bispecific antibody-armed T cells (BATs) before autologous stem cell transplantation (SCT) in patients with sta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ce19618de45916a6e9831e88e562811
https://pubmed.ncbi.nlm.nih.gov/26827660
https://pubmed.ncbi.nlm.nih.gov/26827660
Autor:
Dana Schalk, Lawrence G. Lum, Jason Liu, Archana Thakur, Xiaohua Li, Shijie Sheng, R. Daniel Bonfil, Alexander Kaplun, Sijana H. Dzinic, Qing Sheng Mi, Allen Saliganan, Adelina Mujagic, Hiroshi Yano, Wael Sakr, Elisabeth I. Heath, Elyse N. Tomaszewski, David Krass, Gregory Dyson, Kang Chen, M. Margarida Bernardo, Ivory Dean, Ahmed S. Beydoun, Jessica B. Back
Publikováno v:
Oncotarget
The goal of the current study is to examine the biological effects of epithelial-specific tumor suppressor maspin on tumor host immune response. Accumulated evidence demonstrates an anti-tumor effect of maspin on tumor growth, invasion and metastasis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bdb9680596445743ca350879e6bb1806
https://pubmed.ncbi.nlm.nih.gov/25373490
https://pubmed.ncbi.nlm.nih.gov/25373490
Autor:
Lawrence G. Lum, Fazlul H. Sarkar, Sri Vidya Kondadasula, Hiroshi Yano, Dana Schalk, Archana Thakur, Elyse N. Tomaszewski
Publikováno v:
Journal of Translational Medicine
Background Myeloid-derived suppressor cells (MDSCs) are one of the major components of the immune-suppressive network, play key roles in tumor progression and limit therapeutic responses. Recently, we reported that tumor spheres formed by breast canc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9dcfcbf6a776c95a98184ff39d2f5834
https://doi.org/10.1186/1479-5876-11-35
https://doi.org/10.1186/1479-5876-11-35
Autor:
Qin Liu, Lawrence G. Lum, Elyse N. Tomaszewski, Zaid Al-Kadhimi, Archana Thakur, Joseph P. Uberti, Dana Schalk, Voravit Ratanatharathorn, Ritesh Rathore
Publikováno v:
Journal of Clinical Oncology. 33:3076-3076
3076 Background: In a recent phase I immunotherapy (IT) study in 23 women with metastatic breast cancer (MBC), 8 infusions of activated T cells (ATC) armed with anti-CD3 x anti-HER2Bi bispecific an...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e6eaea86f812a521753fb46cfb2f5e64
https://doi.org/10.1200/jco.2015.33.15_suppl.3076
https://doi.org/10.1200/jco.2015.33.15_suppl.3076